$69.99
Research Studies:
FREE Shipping on
orders over $200
ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY. The products offered on this website are intended solely for research and laboratory use. These products are not intended for human or animal consumption. They are not medicines or drugs and have not been evaluated or approved by the FDA to diagnose, treat, cure, or prevent any disease or medical condition. Any form of bodily introduction is strictly prohibited by law.
Tesamorelin 5mg is a research-use-only laboratory material supplied for controlled research workflows, compound characterization, and analytical documentation review. It is manufactured under rigorous quality standards to support consistency, traceability, and batch-specific verification for qualified laboratory settings.
Tesamorelin 5mg is intended strictly for laboratory research use only. This product is not intended for human or animal consumption, therapeutic use, diagnostic use, clinical use, veterinary use, or as a food, drug, cosmetic, dietary supplement, or household product.
| CAS No. | 901758-09-6 |
|---|---|
| Purity | ≥99% |
| Sequence | Trans-3-Hexenoyl-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH2 |
| Molecular Formula | C221H366N72O67S |
| Molecular Weight | 5135.89 g/mol |
| Synthesis | Solid-phase synthesis |
| Format | Lyophilized powder |
| Solubility | Soluble in water or 1% acetic acid |
| Stability & Storage | Stable for up to 24 months at -20°C. After reconstitution, may be stored at 4°C for up to 4 weeks or at -20°C for up to 6 months. |
| Applications | Growth hormone secretion studies, metabolic regulation research, obesity therapy research |
| Appearance | White lyophilized powder |
| Shipping Conditions | Shipped at ambient temperature; once received, store at -20°C |
| Regulatory/Compliance | Manufactured in a facility that adheres to cGMP guidelines |
| Safety Information | Refer to provided MSDS |
Consider these supplementary peptides for a comprehensive research approach.
Researchers searching for buy Tesamorelin online should evaluate Tesamorelin as a research-use-only laboratory material, not a consumer product. For laboratory buyers, the key considerations are compound identity, purity documentation, batch-specific COAs, lot traceability, product labeling, and storage information. This guide explains how to evaluate Tesamorelin for controlled research procurement through Pure Lab Peptides while keeping the discussion limited to documentation, analytical review, and supplier evaluation.
Researchers can buy Tesamorelin online for laboratory research by reviewing RUO labeling, batch-specific COA documentation, purity data, identity information, storage guidance, and supplier transparency before selecting a source. Products discussed in this article are intended for laboratory research use only and are not intended for human or animal consumption.
The phrase “buy Tesamorelin online” is addressed here as laboratory research procurement intent, not personal-use intent. Qualified researchers, laboratory buyers, research institutions, and technical procurement teams use this type of search to compare RUO labeling, analytical documentation, purity information, compound identity support, and supplier transparency.
In a research procurement setting, the question is not how a compound is used in a person or animal. The question is whether the Tesamorelin research material is documented clearly enough for laboratory records. That includes checking the product name, lot number, batch-specific certificate of analysis, analytical method, storage information, and consistency between product page language and documentation.
RUO language also matters because intended-use statements must be consistent with supplier claims. FDA guidance for RUO and IUO in vitro diagnostic products illustrates the broader compliance principle that research labeling should align with research positioning, while 21 CFR 809.10 describes labeling language for certain RUO products in that specific regulatory context [1] [2]. For Tesamorelin research-use-only procurement, the practical takeaway is straightforward: supplier language should avoid dosing, therapeutic, diagnostic, veterinary, or personal-use framing.
Tesamorelin is identified in scientific databases as a peptide compound. PubChem lists Tesamorelin with the molecular formula C221H366N72O67S and provides a structured chemical record for compound identity review [3]. FDA labeling for the regulated medicine describes tesamorelin acetate as a synthetic growth hormone-releasing factor analog made from the 44-amino-acid sequence of human growth hormone-releasing factor with an N-terminal hexenoyl modification [4]. That regulated-medicine literature is useful for compound identity context only; it is not use guidance for RUO materials.
The IUPHAR/BPS Guide to Pharmacology lists tesamorelin as a peptide and describes it as a stabilized synthetic peptide analog of hypothalamic GHRH [5]. ChEMBL and DrugBank also maintain database records for Tesamorelin, which can help laboratory teams compare identifiers, names, and classification language during identity review [6] [7].
In research-category terms, Tesamorelin belongs in the GHRH pathway and peptide analog category. NCBI Gene identifies GHRHR as the gene encoding the growth hormone-releasing hormone receptor, and UniProt provides a protein record for the human GHRH receptor [8] [9]. These pathway references support neutral research classification. They do not create product-use instructions, therapeutic claims, or personal-use guidance.
Researchers search “buy Tesamorelin online” to locate RUO product availability and compare documentation standards. A laboratory procurement team may need Tesamorelin supplier documentation before approving a purchase request, logging a material into an inventory system, or matching a received vial to a batch-specific COA.
The secondary phrase buy Tesamorelin should be interpreted in the same way: as procurement shorthand for research-use-only sourcing. A qualified buyer should review whether the supplier provides a Tesamorelin COA, Tesamorelin purity documentation, Tesamorelin identity testing information, lot-level traceability, product form details, storage language, and clear RUO labeling.
Online availability alone is not a quality signal. A research buyer should evaluate whether the supplier documents the material in a way that supports laboratory recordkeeping and avoids human-use or animal-use positioning.
Researchers evaluating buy Tesamorelin online for laboratory research should focus on documentation rather than promotional language. A strong procurement review combines label review, COA review, analytical method review, and lot matching. Analytical method validation principles are commonly discussed through ICH Q2(R2), while ICH Q14 describes development and lifecycle concepts for analytical procedures [10] [11].
| Evaluation Area | What Researchers Should Review | Why It Matters for RUO Procurement |
| RUO labeling | Confirm the product is clearly labeled for research use only | Helps separate research procurement from human-use positioning |
| COA availability | Review batch-specific certificate of analysis | Supports lot-level documentation and quality review |
| Purity data | Look for analytical support for the stated purity | Helps evaluate material consistency |
| Identity testing | Review HPLC, LC-MS, mass spectrometry, or related identity data where available | Helps confirm the material matches the listed compound |
| Lot traceability | Match lot numbers across product and documentation | Supports research recordkeeping |
| Product form | Confirm whether the material is supplied as lyophilized powder or another documented form | Supports laboratory planning |
| Storage information | Review storage and handling documentation | Helps maintain material integrity in laboratory settings |
| Supplier language | Confirm the supplier avoids dosing, therapeutic, or personal-use claims | Supports research-use-only positioning |
A Tesamorelin COA should be reviewed as a batch-level document. Researchers should look for the compound name, lot number, product form, test date, purity percentage, analytical method, identity confirmation, and any chromatogram or mass data included in the supplier documentation. FDA bioanalytical guidance emphasizes that documented methods, validation summaries, and analytical records are central to reliable analytical reporting in regulated bioanalytical contexts [12].
A purity percentage alone does not establish complete compound identity; researchers should evaluate purity, identity, method, lot number, and documentation together. HPLC is widely used for peptide analysis and purification, and LC-HRMS has been discussed as a quality-control approach for peptide-related impurity and identity work [13] [14]. Peptide impurity literature also shows why related substances, sequence variants, and degradation products can matter in peptide quality review [15].
For laboratory procurement, method context matters. A chromatographic purity value can help evaluate consistency, while mass spectrometry or LC-MS information can support molecular identity. Two-dimensional chromatographic approaches have also been discussed for peak-purity assessment in pharmaceutical peptide methods [16]. Storage documentation should be reviewed alongside analytical documentation because stability guidance treats temperature, humidity, light, and time as relevant quality variables [17]. WHO storage and transport guidance similarly emphasizes documented control of storage and distribution conditions for time- and temperature-sensitive materials [18].
Published literature discusses Tesamorelin in several contexts, including compound classification, GHRH pathway research, database annotation, analytical detection, and clinical literature outside the scope of RUO product use. Wang and Tomlinson reviewed Tesamorelin as a human growth hormone-releasing factor analog in 2009, while later reviews summarized clinical literature involving regulated medicine contexts [19] [20].
Those publications are not instructions for RUO material handling. Published clinical literature should not be interpreted as use guidance for RUO materials. Bedimo and colleagues reviewed growth hormone and Tesamorelin literature in HIV-associated lipodystrophy, and Falutz and colleagues published pooled clinical-trial analysis of Tesamorelin as TH9507 [21] [22]. For this procurement guide, those sources are cited only to establish that human clinical literature exists outside the scope of RUO product use.
Other research has examined GHRH analog biology, receptor context, and analytical detection. Stanley and colleagues evaluated a GHRH analog in a human study context, while Knoop and colleagues described LC-HRMS/MS identification of growth hormone-releasing hormones in plasma [23] [24]. More recent analytical literature has addressed chromatographic-mass spectrometric analysis of peptidic analytes and nano-LC quadrupole/orbitrap MS analysis of GHRH analogs including tesamorelin [25] [26].
Pathway relevance in published literature does not establish product-use guidance for RUO materials. The safe interpretation is documentation-focused: published literature can inform compound classification, analytical method awareness, and research context, but it should not be converted into dosing, administration, therapeutic, diagnostic, wellness, or consumer claims.
| Research Area | What Literature Examines | Evidence Type | RUO Interpretation |
| Compound identity | Molecular structure, sequence, formula, or classification | Database / analytical | Supports identification, not product-use claims |
| Pathway or category context | GHRH receptor pathway and peptide analog research area | Review / database / analytical | Useful for research context, not therapeutic claims |
| Analytical testing | Purity, identity, and batch verification | HPLC / LC-MS / mass spectrometry / COA | Supports documentation review |
| Storage and stability | Material form and handling considerations | Laboratory documentation | Supports research workflow planning |
| Research-Safe Statement | Why It Is Acceptable | Non-Compliant Version to Avoid |
| “Tesamorelin is discussed in published research related to GHRH pathway literature.” | Describes literature context without making a product claim | “Tesamorelin helps with human outcomes.” |
| “Researchers should review COA and identity data before procurement.” | Focuses on documentation and quality review | “Users should buy Tesamorelin for results.” |
| “Pure Lab Peptides supplies Tesamorelin as a research-use-only material.” | Clarifies intended use | “Pure Lab Peptides supplies Tesamorelin for therapy.” |
| “The phrase buy Tesamorelin online is addressed as research procurement intent.” | Qualifies commercial search intent | “Buy Tesamorelin online for personal use.” |
| “Tesamorelin identity testing should be reviewed with lot-specific documentation.” | Connects identity review to procurement records | “Supplier claims can replace analytical documentation.” |
Pure Lab Peptides presents Tesamorelin 5mg as a research-use-only material for qualified laboratory procurement. The fixed product information for this article identifies the product form as lyophilized powder, the purity claim as ≥99% purity, and the COA status as available. Researchers should review the batch-specific COA, product page documentation, purity information, storage and handling documentation, and lot-level traceability before completing procurement records.
Review the Pure Lab Peptides Tesamorelin research-use-only product details for RUO labeling, product details, purity information, and batch-specific documentation. Research teams comparing suppliers may also review the broader research peptide collection to evaluate documentation consistency across RUO materials.
Buy Tesamorelin online should not be interpreted as personal-use guidance on this page. The phrase is addressed as laboratory procurement intent for qualified researchers reviewing RUO labeling, documentation, purity data, identity information, lot traceability, and supplier transparency.
Published literature can help identify research categories, analytical methods, compound names, and database identifiers. It should not be converted into product-use guidance for RUO materials. Published clinical literature should not be interpreted as use guidance for RUO materials.
A stated purity percentage is only one part of a documentation review. Researchers should review Tesamorelin purity documentation together with identity data, method information, lot number, test date, product name consistency, and COA traceability.
For research procurement, batch-specific documentation is important because the COA should correspond to the material received. Researchers should match the lot number on the label, product record, and Tesamorelin COA before filing laboratory documentation.
RUO labeling does not support human-use, animal-use, clinical, diagnostic, veterinary, or consumer positioning. A Tesamorelin research-use-only listing should remain limited to research procurement, laboratory documentation, supplier evaluation, and controlled research recordkeeping.
Supplier language should be supported by documentation. Research teams should prioritize batch-specific COAs, identity testing, purity information, lot traceability, and storage documentation over broad promotional claims. Tesamorelin supplier documentation should be specific enough for procurement records.
Researchers can buy Tesamorelin online for laboratory research by reviewing RUO suppliers that provide clear product labeling, batch-specific COA documentation, purity information, identity support, storage details, and lot traceability. Pure Lab Peptides provides a Tesamorelin 5mg product page for researchers evaluating documentation before procurement.
Before buying Tesamorelin online, researchers should check RUO labeling, product form, lot number consistency, batch-specific COA availability, purity documentation, analytical method information, identity testing, and supplier language. The supplier should avoid dosing, therapeutic, clinical, veterinary, diagnostic, or personal-use positioning.
A COA matters when buying Tesamorelin because it supports batch-level documentation. Researchers should review whether the COA lists the compound name, lot number, test date, purity value, analytical method, and identity confirmation. A COA should be evaluated with the product label and procurement record.
Tesamorelin discussed on this page is not intended for human or animal consumption. This article addresses Tesamorelin as a research-use-only laboratory material. It does not provide dosing, preparation, administration, clinical, veterinary, diagnostic, therapeutic, wellness, or personal-use guidance.
Research use only means Tesamorelin is positioned as a laboratory research material for qualified researchers and technical procurement teams. The procurement review should focus on labeling, COA documentation, purity data, identity testing, lot traceability, storage information, and supplier transparency.
Published literature about Tesamorelin should be interpreted as scientific context, not product-use guidance. Database records and analytical publications can support identity and method awareness. Clinical literature, where it exists, should not be applied to RUO materials or converted into product claims.
Qualified researchers evaluating Tesamorelin should review product labeling, COA status, identity documentation, storage information, and supplier transparency. Review the Tesamorelin product page for RUO labeling, purity information, and available batch-specific documentation before selecting any research-use-only material.
Our team is ready to assist you with any inquiries regarding our catalogue of peptides and their applications.
Discount Applied Successfully!
Your savings have been added to the cart.
There are no reviews yet.